Physician-scientists pioneer new surgical approach to treat progressive blindness

Dry age-related macular degeneration (dry AMD) poses a significant clinical challenge. It is one of the leading causes of progressive blindness, robbing millions of people over the age of 65 of their central vision, and it often hinders Read More »

April 7th, 2020|Announcements, Clinical Studies, Keck Net Intranet|

New clinical trial examines a potential noninvasive solution for overactive bladder

Keck Medicine of USC urologists are launching a clinical trial to evaluate the effectiveness of spinal cord stimulation in patients with an overactive bladder due to neurological conditions — such as a spinal cord injury or Read More »

March 11th, 2020|Announcements, Clinical Studies, Keck Net Intranet|

A drug deployed at the earliest hint of Alzheimer’s could stop or slow the disease

The Keck School of Medicine of USC is launching a large clinical study to determine whether a man-made antibody would slow or stop the progression of Alzheimer’s disease by targeting memory-robbing plaques in the earliest stages of the illness.

Described as Read More »

February 7th, 2020|Announcements, Clinical Studies, Keck Net Intranet|

Researcher launches study to help the hearing impaired gain access to music

When Ray Goldsworthy, PhD, was just 13, he contracted spinal meningitis. Antibiotics saved his life but destroyed the cells in his inner ears responsible for processing sound.

“Within the span of one to two weeks, I went from hearing normally to Read More »

December 6th, 2019|Announcements, Clinical Studies, Keck Net Intranet|

ATRI to lead consortium on Down syndrome, Alzheimer’s disease

The Alzheimer’s Therapeutic Research Institute (ATRI) of the Keck School of Medicine of USC is one of 25 premier research institutions that received a $4.7 million award to advance research on Down syndrome. The project, titled “Clinical Trials to Prevent Read More »

October 7th, 2019|Announcements, Clinical Studies, Keck Net Intranet|